The FDA has approved an autoinjector formulation of Zilbrysq, a complement inhibitor for the treatment of generalized myasthenia gravis.

While the national burden of pediatric-onset multiple sclerosis is stable, regional incidence and disability rates are increasing in some states.

Starting disease-modifying therapy within 90 days of a neuromyelitis optica spectrum disorder attack may improve long-term disability recovery.

Eden Brothers, Home Grown, and Gardeners Basics are recalling certain lots and brands of broccoli seeds following potential salmonella contamination.

Dexmedetomidine administration is rising in opioid use disorder-related hospitalizations due to medetomidine appearing in illicit fentanyl.

Women with polyendocrine metabolic ovarian syndrome have an elevated risk for Alzheimer disease driven by metabolic dysfunction.

Laxative misuse and dietary restriction in bulimia nervosa are associated with specific structural brain changes including lower hippocampal volume.

Higher levels of physical activity are associated with slower cognitive and motor progression among people with mild-to-moderate Parkinson disease.

There is a higher risk for later ADHD diagnosis associated with low levels of placental growth factor during the third trimester.

Machine learning models utilizing cardiovascular and lifestyle factors can accurately predict the 10-year risk of dementia in both men and women.

The prevalence of unruptured intracranial aneurysms has risen in recent years, particularly among older adults and women.

The MSToronto2026 conference will feature new research on multiple sclerosis diagnosis, biomarkers, and emerging therapeutic ...